Vasoactive Medication for Kidney Transplant

This trial aims to determine if vasopressin, a medication that tightens blood vessels, can enhance the body's response to fluids during kidney transplant surgery. Researchers will compare its effectiveness to another treatment, calcium chloride. Participants will receive treatments based on their blood flow type: vasopressin, norepinephrine, calcium chloride, or fluids. This method is part of a phenotype-guided vasoactive management strategy. Individuals undergoing a kidney transplant at Cedars-Sinai Medical Center who can consent might be suitable for this trial. As a Phase 4 trial, this research focuses on an FDA-approved treatment to understand its benefits for more patients, offering participants the chance to contribute to improved care strategies.

Research has shown that the treatments in this trial, such as vasopressin and norepinephrine, have long been used in hospitals. Vasopressin helps improve blood flow and maintain steady blood pressure during surgeries. Norepinephrine also supports blood pressure.

Researchers are excited about the phenotype-guided vasoactive management protocol because it personalizes treatment during kidney transplants based on the patient's unique circulatory profile. Unlike standard care that typically uses a one-size-fits-all approach with medications like norepinephrine or dopamine, this protocol tailors the vasoactive support—using vasopressin, norepinephrine, calcium chloride, or fluid-guided support—according to the patient's specific physiological needs. This individualized approach aims to optimize blood flow and improve transplant outcomes, potentially setting a new standard for kidney transplant surgeries.

Research has shown that a personalized approach to managing blood flow during kidney transplants can lead to better outcomes. In this trial, participants will follow a phenotype-guided vasoactive protocol, selecting medications based on individual blood circulation patterns. For instance, vasopressin helps those with hyperdynamic physiology by narrowing blood vessels to maintain steady blood pressure during surgery. Studies also indicate that the right combination of fluids and medications can reduce post-transplant complications. Overall, this approach aims to enhance kidney function and recovery for transplant patients.⁶⁷⁸⁹¹⁰